How to Read a Peptide Certificate of Analysis

Here is a fact that should change how you read every peptide COA you ever see.

A peptide missing a single amino acid can appear 99% pure on an HPLC report — and be 0% the compound you ordered.

Both statements are true simultaneously. The sample genuinely contains one dominant substance at 99% of the total. That substance is simply the wrong molecule. HPLC measured what it is designed to measure and reported it accurately. It cannot tell you that the peptide is one residue short, because that is not what purity means.

This is the single most important thing to understand about a peptide COA, and it explains why a certificate with only one test on it is not worth much. What follows is how to read the whole thing properly — what each figure means, which combinations matter, and where the genuine red flags are.

Everything here concerns documentation for research compounds supplied for laboratory use only, not medicines or products for human consumption.

What a COA Actually Is

A certificate of analysis — almost always shortened to COA — is a laboratory-generated document reporting test results for one specific production lot of a compound.

That last part carries the weight. A certificate is not a statement about a product line, a supplier’s general standards, or what a compound usually measures. It is a measurement of a particular batch of material, taken at a particular time, tied to a particular identifying number.

A document that describes the product without identifying the batch is marketing. A document that identifies the batch and reports measured values against named methods is analytical documentation. The two look similar at a glance and mean entirely different things.

Where the Impurities Come From

Understanding how peptides are made explains almost everything a COA reports, because every figure on the document traces back to a step in the process.

Research peptides are built by solid-phase peptide synthesis. The growing chain stays anchored to a solid resin bead while amino acids are added one at a time, from the C-terminal end backwards. Each addition is a cycle: deprotect the end of the chain, couple the next amino acid, wash away the excess, repeat.

For a ten-residue peptide that is nine coupling cycles. For a thirty-residue peptide, twenty-nine. And crucially, no coupling step is 100% efficient.

Suppose each cycle achieves 99% completion — which is good. After nine cycles, the proportion of chains that received every residue correctly is 0.99⁹, or about 91%. After twenty-nine cycles it is 0.99²⁹, around 75%. The arithmetic is unforgiving, and it is the fundamental reason longer peptides are harder to produce at high purity.

The chains that failed a coupling become the impurities a COA reports:

Deletion sequences — a chain that skipped one residue and carried on. These are the dangerous ones, because they are close enough in mass and behaviour to be difficult to separate, and they are the origin of the 99%-pure-but-wrong scenario.

Truncated sequences — a chain where synthesis stopped early. Easier to separate chromatographically because the mass difference is larger.

Side-reaction products — unintended chemistry during synthesis or during cleavage from the resin.

After synthesis the peptide is cleaved from the resin, purified by preparative HPLC, and lyophilised into the dry cake supplied in the vial. The purification step removes most impurities. The COA documents what survived it.

This is why a COA with a chromatogram is more informative than one with a bare percentage. The peaks are a record of the synthesis, and their pattern tells you how well it was controlled.

The Two Tests That Matter, and Why Neither Suffices Alone

A complete certificate rests on two analyses that answer two different questions.

HPLC answers: how much of this is the target compound?

High-performance liquid chromatography separates a mixture by pushing it through a tightly packed column under pressure. Different substances travel at different speeds and emerge at different times. A detector at the column exit records everything that passes, drawing a peak each time something comes through.

The output is a chromatogram — peaks plotted against time. The area under each peak is proportional to how much of that substance is present, and purity is calculated by area normalisation: the main peak’s area as a percentage of total peak area.

For peptide analysis, ultraviolet detection at 214 to 220 nanometres is standard. That wavelength range detects the peptide bond itself, which means it responds to peptide material generally rather than to any particular sequence.

Mass spectrometry answers: is this the right molecule?

Mass spectrometry ionises the sample and measures the mass-to-charge ratio of the resulting particles with high precision. The measured mass is then compared against the theoretical mass calculated from the expected amino acid sequence.

Every peptide has a molecular weight determined entirely by its composition. Get the sequence right and the mass matches. Get it wrong — a missing residue, a substitution, an incomplete modification — and it does not.

On modern LC-MS/MS instruments, mass accuracy should fall within about 5 parts per million. A certificate reporting mass agreement only to within 0.1% is reporting a tolerance roughly 200 times looser than the instrument is capable of, which is worth noticing.

Why you need both

The division is clean and worth memorising.

A certificate with only HPLC tells you the sample is pure but not what it is.

A certificate with only mass spectrometry tells you the molecule is correct but not how much else is in the vial.

The opening example is the extreme case. A deletion sequence — a peptide synthesised one residue short — is a single consistent substance. HPLC sees one dominant peak and reports high purity. Mass spectrometry sees a molecular weight that does not match and flags it immediately.

Run one test and you have half a picture. Run both and you know both how much and what.

Reading a COA Top to Bottom

Certificates vary in layout but contain the same elements. Here is the order to check them in.

Step one: match the batch number

The top of the certificate identifies the product and — critically — the lot or batch number.

Compare it against the number printed on your vial. If they do not match, the certificate does not describe your material. It may be a perfectly valid certificate for a different batch, which is no help at all.

This is the check most often skipped and the one that matters most. Everything downstream is meaningless if the document describes other material.

Step two: check the HPLC purity figure and its method

Look for the purity percentage, then look for the method beside it. A purity value should always be paired with a named analytical method — HPLC-UV or LC-MS — because a number without a method is not a measurement.

A thorough certificate specifies the method parameters: column type, mobile phase composition, flow rate and detection wavelength. A typical peptide analysis might use a C18 column with 0.1% trifluoroacetic acid in water and acetonitrile as the mobile phases, a defined gradient, and UV detection at 220 nm.

Those details are not padding. They establish that a real separation was performed under conditions appropriate to the compound.

Step three: compare theoretical and observed mass

The certificate should list a theoretical mass — calculated from the sequence — and an observed mass — what the instrument measured.

These should agree closely. A discrepancy is informative rather than merely disqualifying, because common gaps have known causes:

16 Da higher suggests oxidation, typically at a methionine, cysteine or tryptophan residue.

18 Da higher on a cyclic peptide suggests incomplete cyclisation — the ring never closed, so the water molecule that would have been eliminated is still present.

Lower by the mass of one residue indicates a deletion sequence.

Lower by 42 Da on an acetylated peptide suggests the acetyl group is missing.

Learning to read those differences turns a mismatch from a failure into a diagnosis.

Step four: read the chromatogram, not just the number

Where the certificate includes the chromatogram image, it deserves more attention than the summary figure.

A purity figure above 95% sounds acceptable. A chromatogram showing significant secondary peaks or an elevated baseline tells a different story than that single number does.

What good looks like: one dominant peak, minimal baseline noise, few secondary peaks, and a flat baseline returning cleanly between features.

What warrants questions: a cluster of small peaks immediately adjacent to the main one, which typically indicates deletion sequences or stereochemical impurities. An elevated or drifting baseline, which can indicate residual solvent or column problems. Broad, poorly resolved peaks suggesting inadequate separation.

A real synthesis example from the patent literature illustrates the value of looking. In one reported analysis, the main product peak appeared at 41.48 minutes with the expected mass. An additional peak at 41.21 minutes — just 0.27 minutes earlier, very close on the chromatogram — carried a mass 72 Da higher than the full-length product. Two substances, almost identical retention, entirely different molecules. Only the mass analysis distinguished them.

Step five: check appearance and the overall result

The certificate records physical characteristics — typically something like “white lyophilised powder”. For copper peptide complexes, expect a blue to blue-violet description instead, since the copper coordination produces colour.

Then check that the overall result reads PASS against the stated specification.

The Specification Almost Nobody Checks

Here is where certificates get genuinely misread, and it is not about either of the two main tests.

Purity and net peptide content are different measurements, and confusing them produces quantitative errors of 10% to 40%.

Purity is what proportion of the peptide material present is your target sequence.

Net peptide content is what proportion of the total dry mass is peptide at all, rather than counterions, residual water and bound salts.

Lyophilised peptide is not pure peptide by weight. Trifluoroacetate counterions from purification, absorbed atmospheric moisture and residual salts all contribute mass. Net peptide content commonly runs between 60% and 90% depending on sequence.

So a vial labelled 5mg at 99% purity might contain 5mg of dry material, of which perhaps 80% is peptide — around 4mg of actual compound. A calculation assuming 5mg overstates every quantity prepared from it by roughly 20%.

The two figures are independent. High purity says nothing about content; high content says nothing about purity. The peptide dosage guide covers how to correct for this.

What Neither Test Detects

Three things pass both HPLC and mass spectrometry without being flagged, and knowing them is part of reading a certificate honestly.

Racemisation. An amino acid that has flipped from the L to the D configuration has identical mass. Mass spectrometry cannot see it. Chromatographic separation sometimes can, depending on the system; specialised methods such as enantiomeric purity analysis by GC-MS are required for certainty.

Heavy metals. Invisible to both HPLC and mass spectrometry as ordinarily performed. Detecting them requires ICP-MS — inductively coupled plasma mass spectrometry — which measures metals at parts-per-billion levels. This is a separate test and appears on certificates only when specifically commissioned.

Endotoxin and microbial contamination. Again separate tests, relevant to particular applications and absent from a standard purity and identity certificate.

A certificate reporting HPLC and mass spectrometry is doing its job. It is simply not doing every job, and understanding the boundary prevents over-reading the document.

COA Red Flags Worth Taking Seriously

Some COA problems are structural rather than analytical — they concern what the document does or does not establish, rather than the values it reports.

No batch number, or a number that does not match the vial. The single most serious issue, because it severs the link between document and material.

Only one test. HPLC alone or mass spectrometry alone leaves half the question unanswered.

A purity figure with no named method. “99% pure” without stating how it was determined is a claim rather than a result.

Mass tolerance reported far looser than instruments allow. Agreement quoted to 0.1% where 5 ppm is achievable suggests either old equipment or imprecise reporting.

No date. A certificate records a measurement at a moment. Undated, it cannot be related to the material’s storage history.

Figures reused across batches. If every batch reports precisely the same purity to two decimal places, that is a template rather than a series of measurements. Genuine analysis produces variation — 98.17%, 99.21%, 97.84% — because real measurement does.

What Purity Figure Is Actually Needed

The honest answer depends on the work, and higher is not automatically necessary.

80% or greater is generally adequate for tissue culture, affinity purification ligands and non-quantitative blocking experiments.

90% or greater suits in vivo studies, bioassays and electrophoresis markers.

95% or greater is the general standard for most analytical research.

98% or greater is appropriate where small differences would affect results — quantitative work, receptor binding studies, anything where the remaining fraction could plausibly interfere.

Some sequences legitimately achieve lower purity than others. Peptides containing free cysteine, an N-terminal glutamine, sulfated residues, or unusually long or difficult sequences are harder to produce cleanly. A 95% figure on a difficult 39-residue peptide may represent better synthesis control than 98% on a tripeptide.

Which is why the compound matters when interpreting the number. Context is part of reading the certificate.

Third-Party Testing Versus In-House

One distinction affects how much weight a COA carries, and it is worth being clear about rather than coy.

An in-house COA is produced by the supplier’s own analysis. A third-party COA is produced by an independent laboratory with no commercial interest in the result.

Both can be entirely accurate. The difference is not honesty but verifiability — an independent laboratory has nothing to gain from a favourable number, which removes a category of doubt rather than an actual failure mode.

Some independent laboratories report numerical results without including chromatogram images. That is a presentation choice rather than a deficiency: the absence of a chromatogram does not invalidate the figures, though it does remove the opportunity to read peak shape yourself.

Most third-party testers provide HPLC and mass spectrometry together in a single analysis, and will flag specifically when mass spectrometry fails to detect the expected sequence. That combination — both tests, one independent report, one batch — is the strongest documentation available for a research compound.

What matters more than the label on the letterhead is whether the fundamentals are present: a batch number matching your vial, both tests performed, named methods, a date, and figures that vary between batches as real measurement does.

Related Compounds and Where COAs Differ

Different compound classes shift what deserves attention on the COA, and knowing the compound tells you which figure to scrutinise.

Copper peptides. GHK-Cu and AHK-Cu raise a question ordinary peptides do not: is the copper actually bound? The complexed and uncomplexed forms differ in mass, so mass spectrometry answers it — and the appearance line should describe a blue rather than white solid.

Modified peptides. SNAP-8 carries an acetylated N-terminus and amidated C-terminus. Both modifications shift the mass, so their absence is detectable — and both are essential to the compound’s stability.

Cyclic peptides. Melanotan 2 is a cyclic lactam. The 18 Da signature of incomplete cyclisation is the specific thing to check. Melanotan 1, by contrast, is linear but contains a D-amino acid — which mass spectrometry cannot verify, making the chromatogram the relevant evidence. Oxytocin is cyclised by a disulfide bond rather than a lactam, where dimer formation is the specific concern.

Longer sequences. BPC-157 at 15 residues, TB-500, Sermorelin at 29 and Tesamorelin present more coupling steps and therefore more opportunity for deletion sequences. Expect more adjacent peaks on the chromatogram and read purity figures with chain length in mind.

Short sequences. KPV at three residues, Epitalon at four and Pinealon at three are comparatively straightforward to produce at high purity, and also carry proportionally less counterion mass, so net peptide content sits higher.

Blends. KLOW, GLOW and the Wolverine Stack require the certificate to specify individual component masses, not just the blend total. Protocols are written around single compounds, and calculating from a blend total produces large errors on the minor components.

Secretagogues. Ipamorelin, GHRP-2, GHRP-6 and CJC-1295 with Ipamorelin are typically studied at microgram quantities from milligram vials, which makes the net peptide content figure disproportionately consequential.

How Crown Peptides Handles This

Every batch carries its own certificate rather than a figure carried forward from an earlier production run.

Purity is measured by high-performance liquid chromatography, separating the target compound from related substances and reporting the main peak as a proportion of total peak area. Identity is confirmed independently by mass spectrometry, measuring molecular weight directly and verifying that the compound is the sequence intended rather than something structurally adjacent.

Both are published. The batch number on the vial matches the batch number on the certificate, which is the link that makes the figures a measurement of your material rather than a general claim.

Every published certificate is available through the lab reports library, and scanning the QR code on any vial opens that batch’s report directly. Reconstitution arithmetic is handled by the peptide calculator, and storage guidance is set out in the storage information guide.

Frequently Asked Questions

What is a peptide COA?

A laboratory document reporting analytical results for one specific production lot — typically purity by HPLC, identity by mass spectrometry, and physical characteristics, tied to a batch number that should match the vial.

What is the difference between HPLC and mass spectrometry on a peptide COA?

HPLC measures purity — what proportion of the sample is the target compound. Mass spectrometry confirms identity — whether the molecule’s measured mass matches the expected mass. One answers how much, the other answers what.

Can a peptide be 99% pure and still be wrong?

Yes, and this is the central reason both tests are needed. A peptide missing one amino acid is a single consistent substance and can report 99% purity on HPLC while being 0% the intended compound. Only mass spectrometry detects it.

What purity should I look for?

95% or above for most analytical research, 98% or above where small differences affect results. Difficult sequences — long chains, free cysteine, sulfated residues — legitimately achieve lower figures, so chain length and composition matter when interpreting the number.

What does net peptide content mean?

The proportion of total dry mass that is peptide rather than counterions, residual water and salts — commonly 60% to 90%. It is entirely separate from purity, and ignoring it overstates every calculated quantity.

Why does the batch number matter so much?

Because a certificate documents one specific production lot. If the number on the certificate does not match the number on the vial, the document describes different material and its figures do not apply to yours.

What does the chromatogram add beyond the purity number?

Shape. A single dominant peak with a clean baseline indicates well-controlled synthesis. Significant secondary peaks or an elevated baseline tell a different story than the summary percentage alone, particularly a cluster of peaks adjacent to the main one.

Do certificates test for heavy metals?

Not as standard. Heavy metals are invisible to both HPLC and mass spectrometry and require ICP-MS, a separate analysis that appears only when specifically commissioned.

What should make me doubt a COA?

A missing or mismatched batch number, only one test performed, a purity figure with no named method, no date, or identical figures repeated across multiple batches — real measurement produces variation.

Should a COA include a chromatogram image?

It is genuinely useful when present, because peak shape carries information the summary percentage does not. Some laboratories report numerical results only as a matter of presentation, which does not invalidate the figures — it simply means you are relying on their integration rather than reading the separation yourself.

How often should a supplier issue a new COA?

Once per production batch. A COA describes the material from one synthesis and purification run, so a new batch requires new analysis. A supplier reusing one document across multiple batches is not documenting the material they are shipping.

Does a COA tell me how long the peptide will last?

No. It records what the material was at the moment of testing. Shelf life depends on storage conditions from that point onward, which no certificate can account for. Where material has been held well beyond its expected window, fresh HPLC analysis is the only reliable answer — the shelf life guide covers this in detail.

The Habit Worth Building

Reading a certificate properly takes about ninety seconds once the sequence is familiar. Match the batch number to the vial. Check the purity figure has a named method. Compare theoretical against observed mass. Glance at the chromatogram shape if it is included. Note the net peptide content if it is stated.

That routine catches nearly everything that can be caught from a document — and it also tells you what the document cannot catch, which is arguably as useful.

The 99%-pure-and-entirely-wrong scenario is not a hypothetical. It is the specific failure mode that one test cannot see and two tests can, and it is the reason certificates are worth reading rather than filing.

Every batch in the Crown Peptides range is HPLC and mass spectrometry verified, with the full certificate published openly against its batch number.